Erleada: payments to doctors
Payments that named Erleada as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $16.8M
- Providers
- 23,404
- Transactions
- 168,541
- Average per transaction
- $99
The per-transaction average — $99 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,404 providers the average total is $716, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $14,804,927 | 88.4% |
| Janssen Scientific Affairs, LLC | $1,073,848 | 6.4% |
| Janssen Research & Development, LLC | $561,816 | 3.4% |
| Janssen Global Services, LLC | $309,454 | 1.8% |